BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 05/17/2013
Entire Document
 
 

 

Exhibit Index
  
Exhibit 5.1
Opinion of Yigal Arnon & Co., Israeli Counsel to the Company
Exhibit 5.2
Opinion of Morrison & Foerster LLP, U.S. Counsel to the Company
Exhibit 10.1
At-the-Market Equity Offering Sales Agreement between BioLineRx Ltd. and Stifel, Nicolaus & Company, Incorporated dated May 17, 2013
Exhibit 99.1
Press Release issued on May 17, 2013